PIPELINE

Pipeline

Pipeline table
Pipeline Target Indication Discovery Pre-clinical Phase 1 Phase 2 Phase 3
MFC0101
(BBB Permeable)
Glioblastoma
37%
Solid Tumor
30%
Brain Metastases
20%
MFC0102
(Non-BBB Permeable)
MASH
15%
Solid Tumor
15%
MFC0201 Glioblastoma
9%
Leukemia
9%
MFC0301 Glioblastoma
13%